These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27882937)

  • 1. EZH2 mediates lidamycin-induced cellular senescence through regulating p21 expression in human colon cancer cells.
    Sha MQ; Zhao XL; Li L; Li LH; Li Y; Dong TG; Niu WX; Jia LJ; Shao RG; Zhen YS; Wang Z
    Cell Death Dis; 2016 Nov; 7(11):e2486. PubMed ID: 27882937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTTG1 attenuates drug-induced cellular senescence.
    Tong Y; Zhao W; Zhou C; Wawrowsky K; Melmed S
    PLoS One; 2011; 6(8):e23754. PubMed ID: 21858218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells.
    Li Y; Li D; Zhao M; Huang S; Zhang Q; Lin H; Wang W; Li K; Li Z; Huang W; Che Y; Huang C
    Life Sci; 2018 Sep; 208():295-304. PubMed ID: 30031062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
    Chen J; Ouyang ZG; Zhang SH; Zhen YS
    Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
    Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
    J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference of cell cycle arrests induced by lidamycin in human breast cancer cells.
    Liu X; He H; Feng Y; Zhang M; Ren K; Shao R
    Anticancer Drugs; 2006 Feb; 17(2):173-9. PubMed ID: 16428935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.
    Chen Y; Pan K; Wang P; Cao Z; Wang W; Wang S; Hu N; Xue J; Li H; Jiang W; Li G; Zhang X
    J Biol Chem; 2016 Jun; 291(24):12688-12705. PubMed ID: 27129219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis.
    Pan Y; Ren KH; He HW; Shao RG
    Cancer Biol Ther; 2009 Aug; 8(16):1559-66. PubMed ID: 19502782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target.
    Cao J; Pontes KC; Heijkants RC; Brouwer NJ; Groenewoud A; Jordanova ES; Marinkovic M; van Duinen S; Teunisse AF; Verdijk RM; Snaar-Jagalska E; Jochemsen AG; Jager MJ
    J Pathol; 2018 Aug; 245(4):433-444. PubMed ID: 29732557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
    Shang BY; Shang Y; Zhen YS; Chen SZ
    Yao Xue Xue Bao; 2011 Nov; 46(11):1321-5. PubMed ID: 22260022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.
    Fan T; Jiang S; Chung N; Alikhan A; Ni C; Lee CC; Hornyak TJ
    Mol Cancer Res; 2011 Apr; 9(4):418-29. PubMed ID: 21383005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21.
    Liu L; Xu F; Chang CK; He Q; Wu LY; Zhang Z; Li X
    Cell Death Dis; 2017 Oct; 8(10):e3126. PubMed ID: 29022893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp90 inhibitor geldanamycin enhances the antitumor efficacy of enediyne lidamycin in association with reduced DNA damage repair.
    Han FF; Li L; Shang BY; Shao RG; Zhen YS
    Asian Pac J Cancer Prev; 2014; 15(17):7043-8. PubMed ID: 25227788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lidamycin induces marked G2 cell cycle arrest in human colon carcinoma HT-29 cells through activation of p38 MAPK pathway.
    Liu X; Bian C; Ren K; Jin H; Li B; Shao RG
    Oncol Rep; 2007 Mar; 17(3):597-603. PubMed ID: 17273739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting enhancer of zeste homolog 2 promotes cellular senescence in gastric cancer cells SGC-7901 by activation of p21 and p16.
    Bai J; Chen J; Ma M; Cai M; Xu F; Wang G; Tao K; Shuai X
    DNA Cell Biol; 2014 Jun; 33(6):337-44. PubMed ID: 24588771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 dependent and independent apoptosis induced by lidamycin in human colorectal cancer cells.
    Chen L; Jiang J; Cheng C; Yang A; He Q; Li D; Wang Z
    Cancer Biol Ther; 2007 Jun; 6(6):965-73. PubMed ID: 17534142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer.
    Liu JQ; Feng YH; Zeng S; Zhong MZ
    Life Sci; 2020 Jan; 241():117134. PubMed ID: 31811854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lidamycin on telomerase activity in human hepatoma BEL-7402 cells.
    Gao RJ; Liang YX; Li DD; Zhang HY; Zhen YS
    Biomed Environ Sci; 2007 Jun; 20(3):189-97. PubMed ID: 17672208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lnc-IL7R alleviates PM
    Lee KY; Ho SC; Sun WL; Feng PH; Lin CW; Chen KY; Chuang HC; Tseng CH; Chen TT; Wu SM
    Cell Biol Toxicol; 2022 Dec; 38(6):1097-1120. PubMed ID: 35303175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.
    Yu Y; Qi J; Xiong J; Jiang L; Cui D; He J; Chen P; Li L; Wu C; Ma T; Shao S; Wang J; Yu D; Zhou B; Huang D; Schmitt CA; Tao R
    Theranostics; 2019; 9(3):761-777. PubMed ID: 30809307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.